Organization · Tulsa and Oklahoma ecosystem
Wheeler Bio
Biologics development. Listed in the linked investors’ public portfolios; a portfolio listing does not establish current operating or fundraising status.
For example: Explore Wheeler Bio through its official site and connected entries to check whether it fits your needs.
Funding
- Raised a $35 million Series A-1 in March 2025, led by Alloy Therapeutics and Echo Investment Capital. Source: wheelerbio.com
- Closed a $31 million Series A in April 2023, co-led by Charles River Laboratories and Echo Investment Capital. Source: wheelerbio.com
- Reported $23,118,965 sold of a $36,513,996 offering in an SEC Form D filed in April 2025. Source: sec.gov
- Reported $23,153,354 sold of a $29,999,986 offering in an SEC Form D filed in October 2022. Source: sec.gov
- Reported $13,647,374 sold of a $14,522,358 offering in an SEC Form D filed in November 2021. Source: sec.gov
Figures are as published by the linked source.
Official site: wheelerbio.com
Connects to 13
- Plains Ventures Investor
- Startup ecosystem Concept
- Alloy Therapeutics Organization, investor
- Echo Investment Capital Investor
- Mitsubishi Corporation (Americas) Organization, investor
- Germin8 Ventures Investor
- Russell Westbrook Enterprises Organization, investor
- Charles River Laboratories Organization, investor
- ATUM Organization, investor
- Floating Point Investor
- Pine Ridge Ventures Investor
- Seagull Capital Investor
- Boyd Street Capital Investor
Sources
- https://www.wheelerbio.com
- https://plainsvc.com/portfolio/
- https://www.okcommerce.gov/wheeler-bio-announces-oversubscribed-35m-series-plans-for-expansion-and-continued-growth/
- https://www.sec.gov/Archives/edgar/data/1895358/000189535822000001/primary_doc.xml
- https://www.sec.gov/Archives/edgar/data/1895358/000189535825000002/primary_doc.xml
- https://www.sec.gov/Archives/edgar/data/1895358/000189535821000001/primary_doc.xml
- https://wheelerbio.com/articles/wheeler-bio-announces-oversubscribed-35m-series-plans-for-expansion-and-continued-growth/
- https://wheelerbio.com/articles/wheeler-bio-announces-closing-of-31-million-series-a-round-supporting-its-clinical-cgmp-drug-substance-manufacturing-facility-in-oklahoma-city/
- https://boydstreetcap.com/portfolio/